Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase*

Clones encoding a new human P2Y receptor, provisionally called P2Y11, have been isolated from human placenta complementary DNA and genomic DNA libraries. The 1113-base pair open reading frame is interrupted by one intron. The P2Y11 receptor is characterized by considerably larger second and third extracellular loops than the subtypes described so far. The deduced amino acid sequence exhibits 33% amino acid identity with the P2Y1 receptor, its closest homolog. Northern blot analysis detected human P2Y11 receptor messenger RNA in spleen and HL-60 cells. The level of P2Y11 transcripts was strongly increased in these cells after granulocyte differentiation induced by retinoic acid or dimethyl sulfoxide. The new receptor was stably expressed in 1321N1 astrocytoma and CHO-K1 cells, where it couples to the stimulation of both the phosphoinositide and adenylyl cyclase pathways, a unique feature among the P2Y family. The rank order of agonists potency was: ATP > 2-methylthio-ATP >>> ADP, whereas UTP and UDP were inactive, indicating that it behaves as a selective purinoceptor.

[1]  T. K. Harden,et al.  Second messenger cascade specificity and pharmacological selectivity of the human P2Y1‐purinoceptor , 1996, British journal of pharmacology.

[2]  J. T. Turner,et al.  Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  I. Matsuoka,et al.  Extracellular ATP stimulates adenylyl cyclase and phospholipase C through distinct purinoceptors in NG108-15 cells. , 1995, Molecular pharmacology.

[4]  S. Chueh,et al.  P2 purinoceptor-mediated inhibition of cyclic AMP accumulation in NG108-15 cells , 1996, Brain Research.

[5]  M. Parmentier,et al.  Cloning, functional expression and tissue distribution of the human P2Y6 receptor. , 1996, Biochemical and biophysical research communications.

[6]  G. Burnstock,et al.  Purinoceptors: are there families of P2X and P2Y purinoceptors? , 1994, Pharmacology & therapeutics.

[7]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Boeynaems,et al.  Cloning of a human heptahelical receptor closely related to the P2Y5 receptor. , 1997, Biochemical and biophysical research communications.

[9]  W. Watt,et al.  Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. , 1996, Molecular pharmacology.

[10]  Y. Takuwa,et al.  Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[11]  J. Cazenave,et al.  The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells , 1997, FEBS letters.

[12]  G. Burnstock,et al.  A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates. , 1996, Molecular pharmacology.

[13]  M. Parmentier,et al.  Cloning and tissue distribution of the human P2Y1 receptor. , 1996, Biochemical and biophysical research communications.

[14]  G Burnstock,et al.  Towards a revised nomenclature for P1 and P2 receptors. , 1997, Trends in pharmacological sciences.

[15]  P. Iredale,et al.  Increases in intracellular calcium via activation of an endogenous P2‐purinoceptor in cultured CHO‐K1 cells , 1993, British journal of pharmacology.

[16]  J. Schrader,et al.  Cloning of the rat P2u receptor and its potential role in coronary vasodilation. , 1996, The American journal of physiology.

[17]  G. Burnstock,et al.  Early Expression of a Novel Nucleotide Receptor in the Neural Plate of Xenopus Embryos* , 1997, The Journal of Biological Chemistry.

[18]  I. Pastan,et al.  Retroviruses expressing different levels of the normal epidermal growth factor receptor: Biological properties and new bioassay , 1989, Journal of cellular biochemistry.

[19]  S. Pirotton,et al.  Pharmacological characterization of the human P2Y4 receptor. , 1996, European journal of pharmacology.

[20]  M. Parmentier,et al.  Cloning and Functional Expression of a Human Uridine Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[21]  J. T. Turner,et al.  Site-directed Mutagenesis of P2U Purinoceptors , 1995, The Journal of Biological Chemistry.

[22]  A. Conigrave,et al.  Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells. , 1997, Biochemical and biophysical research communications.

[23]  E. Barnard,et al.  Identification of 6H1 as a P2Y purinoceptor: P2Y5. , 1996, Biochemical and biophysical research communications.

[24]  D. Julius,et al.  Expression cloning of an ATP receptor from mouse neuroblastoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. T. Turner,et al.  Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor Gene (*) , 1995, The Journal of Biological Chemistry.

[26]  T. Kendall Harden,et al.  An examination of deoxyadenosine 5′(α‐thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor , 1997, British journal of pharmacology.

[27]  E. Barnard,et al.  Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia Cells* , 1996, The Journal of Biological Chemistry.

[28]  Takao Shimizu,et al.  A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.

[29]  E. Raspé,et al.  Coexpression of P2Y and P2U receptors on aortic endothelial cells. Comparison of cell localization and signaling pathways. , 1995, Circulation research.

[30]  G. Burnstock,et al.  Cloning and functional expression of a brain G‐protein‐coupled ATP receptor , 1993, FEBS letters.